Export 131 results:
Filters: First Letter Of Last Name is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Parent, M.. A., Berggren K.. N., Kummer L.. W., Wilhelm L.. B., Szaba F.. M., Mullarky I.. K., et al. (2005).  Cell-Mediated Protection against Pulmonary Yersinia pestis Infection. Infection and Immunity. 73, 11.
Parsi, VK. (2001).  Cholera.
Bédard, E., Boppe I., Kouamé S., Martin P., Pinsonneault L., Valiquette L., et al. (2016).  Combination of heat shock and enhanced thermal regime to control the growth of a persistent Legionella pneumophila strain. Pathogens. 5, 35.
Bédard, E., Boppe I., Kouamé S., Martin P., Pinsonneault L., Valiquette L., et al. (2016).  Combination of heat shock and enhanced thermal regime to control the growth of a persistent Legionella pneumophila strain. Pathogens. 5, 35.
Golnazarian, C.. A., Donnelly C.. W., Pintauro S.. J., & Howard D.. B. (Submitted).  Comparison of infectious dose of Listeria monocytogenes F5817 as determined for normal versus compromised C57B1/6J mice. Journal of food protection. 52, 10.
Pettis, JS. (2013).  Crop pollination exposes honey bees to pesticides which alters their susceptibility to the gut pathogen Nosema ceranae.
Painter, J. E., Hlavsa M. C., Collier S. A., Xiao L., Yoder J. S., & Gargano J. W. (2015).  Cryptosporidiosis surveillance–United States, 2011-2012; Giardiasis surveillance–United States, 2011-2012.
Chambers, H. F., McPhee S. J., Papadakis M. A., & Tierney L. M. (2008).  Current Medical Diagnosis & Treatment. pp. 1250-1252.